MLL advised Plasmalex on the acquisition of the swiss company Coat-X. The incorporation of implantable multilayer COAT-X thin films into Plasmalex’s product range represents a significant expansion of Plasmalex’s portfolio and will enable
MLL advised Plasmalex on the acquisition of the swiss company Coat-X. The incorporation of implantable multilayer COAT-X thin films into Plasmalex’s product range represents a significant expansion of Plasmalex’s portfolio and will enable